Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-α therapy

Journal of Clinical Rheumatology

Volumn 13, Issue 3, 2007, Pages 150-152

  Krishnamurthy, Raghu ^a,c   Dincer, H Erhan ^a   Whittemore, Darren ^b  

^a Interventional Pulmonary and Critical Care Medicine   (United States)

^b Nellis Air Force Base   (United States)

^c NONE   (United States)

Author keywords

Strongyloidiasis

Indexed keywords

ADALIMUMAB; GATIFLOXACIN; IVERMECTIN; METHOTREXATE; PREDNISONE; TIABENDAZOLE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADD ON THERAPY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CELLULAR IMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FECES CULTURE; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; LUNG LAVAGE; MALE; NEMATODIASIS; PARASITE CULTIVATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RHEUMATOID ARTHRITIS; SEPSIS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; SUPERINFECTION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BRONCHOALVEOLAR LAVAGE; DRUG THERAPY, COMBINATION; ENDEMIC DISEASES; GLUCOCORTICOIDS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; METHOTREXATE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PHILIPPINES; PREDNISONE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249980099     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3180690933     Document Type: Article

References (12)

1. Genta RM. Global prevalence of strongyloidasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis. 1989;11:755-767.
2. Parasite and Health. Strongyloidasis. Life cycle. Available online at http://www.dpd.cdc.gov/dpdx.
3. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev. 2004;17:208-217.
4. Coulter C, Walker DG, Gunsberg M, et al. Successful treatment of disseminated strongyloidiasis. 1992;157:331-332.
5. Venizelos PC, Lopata M, Bardawil WA, et al. Respiratory failure due to Strongyloides stercoralis in a patient with renal failure. Chest. 1980;78:104-106.
6. Thompson JR, Berger R. Fatal adult respiratory distress syndrome following successful treatment of pulmonary strongyloides. Chest. 1991;99:772-774.
7. Cook GA, Rodriguez H, Silva H, et al. Adult respiratory distress secondary to strongyloidiasis. Chest. 1987;92:1115-1116.
8. Debussche X, Toublanc M, Camillieri JP, et al. Overwhelming Strongyloidiasis in a diabetic patient following adrenocorticotropin treatment and keto-acidosis. Diabetes Metab. 1988;14:294-298.
9. Hamilton CD. Infectious complications of treatment with biologic agents. Curr Opin Rheumatol. 2004;16:393-398.
10. Wurtz R, Mirot M, Frunda G, et al. Short report: gastric infection by Strongyloides stercoralis. Am J Trop Med Hyg. 1994;51:339-340.
11. Goshal UC, Goshal U, Jain M, et al. Strongyloides stercoralis infestation associated with septicemia due to intestinal transmural migration of bacteria. J Gastroenter Hepat. 2002;17:1331-1333.
12. Drugs for parasitic infections. August 2004. available online at: www.medletter.com/freedocs/parasitic.pdf.